首页> 外文期刊>Journal of clinical laboratory analysis. >Molecular Detection of Trisomy 21 by Bicolor Competitive Fluorescent PCR
【24h】

Molecular Detection of Trisomy 21 by Bicolor Competitive Fluorescent PCR

机译:双色竞争荧光PCR分子检测21三体。

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To develop a reliable and specific method for rapid prenatal diagnosis of Trisomy 21 (Down syndrome). Methods: We established a dual color competitive fluorescent Polymerase Chain Reaction (PCR) to measure the gene dosage of Down syndrome critical region (DSCR), a single copy sequence in chromosome 21. Another unique single copy sequence located on chromosome 2 (USC2) but not glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was chose as reference gene. Results: The DSCR3/USC2 ratio of peripheral blood in trisomy 21 syndrome patients to normal subjects was 1.41~1.74 to 0.93~1.15, respectively (p < 0.01). Dual color competitive fluorescent PCR technique effectively differentiates the normal subjects from the Down syndrome patients. Next, according to the dual color competitive fluorescence quantitative PCR, among the 46 pregnant women, 3 cases were Down syndrome and 43 cases were normal, and these were confirmed by cytogenetic karyotype analysis. Conclusion: This indicated that the new technique may be a reliable and specific method for the rapid prenatal diagnosis of Trisomy 21.
机译:目的:开发一种可靠且具体的方法来快速进行21三体综合征(唐氏综合症)的产前诊断。方法:我们建立了双色竞争荧光聚合酶链反应(PCR),以测量唐氏综合症关键区域(DSCR)的基因剂量,该染色体是21号染色体上的一个单拷贝序列。另一个独特的单拷贝序列位于2号染色体(USC2)上,但是未选择3-磷酸甘油醛脱氢酶(GAPDH)作为参考基因。结果:21三体综合征患者与正常人外周血的DSCR3 / USC2比分别为1.41〜1.74至0.93〜1.15(p <0.01)。双色竞争荧光PCR技术有效地将正常人与唐氏综合症患者区分开。其次,根据双色竞争荧光定量PCR,在46例孕妇中,唐氏综合症3例,正常43例,经细胞遗传核型分析确认。结论:这表明该新技术可能是快速,准确地诊断21三体的产前诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号